Peptide display without phage
Alex Batchelor
CEO, Orbit Discovery
Orbit Discovery is an Oxford spin-out built on novel peptide display technology developed at the University. Our system uniquely links phenotype with genotype on magnetic beads with high display density for both linear and cyclic peptides. We have successfully probed biochemical and cell surface targets and recently raised funding to begin drug discovery activities. Our business model involves development of our own compounds which we will take to early clinical stages as well as collaborative development with partners interested in specific targets.